No Pharmacokinetic Interaction Between HCV NS5A Inhibitor Elbasvir and Buprenorphine/Naloxone in Healthy Volunteers

被引：0
|
作者：
Marshall, William L. [1 ]
Marenco, Ted [2 ]
Feng, Hwa-Ping [1 ]
Barbour, April M. [1 ]
Gilmartin, Jocelyn [1 ]
Liu, Fang [1 ]
Panebianco, Deborah L. [1 ]
Mirzac, Angela [2 ]
Di Spirito, Mike [2 ]
Stypinski, Daria [2 ]
Machnes, Ziv [2 ]
Gartner, Michael [2 ]
Iwamoto, Marian [1 ]
Butterton, Joan R. [1 ]
Yeh, Wendy W. [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Celerion, Lincoln, NE USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
730
引用
收藏
页码：573A / 573A
页数：1
相关论文
共 50 条
  • [1] Lack of Pharmacokinetic Interaction Between HCV Protease Inhibitor MK-5172 and HCV NS5A Inhibitor Daclatasvir in Healthy Volunteers
    Yeh, Wendy W.
    Fraser, Iain P.
    Bifano, Marc
    Caro, Luzelena
    Talaty, Jennifer E.
    Guo, Zifang
    McCarthy, Jennifer M.
    Youngberg, Stephen P.
    Butterton, Joan R.
    HEPATOLOGY, 2013, 58 : 430A - 431A
  • [2] No Pharmacokinetic Interaction Between HCV Protease Inhibitor MK-5172 and HCV NS5A Inhibitor MK-8742 in Healthy Volunteers
    Yeh, Wendy W.
    Caro, Luzelena
    Huang, Xiaobi
    Mangin, Eric
    Jumes, Patricia
    Rasmussen, Scott
    Butterton, Joan R.
    HEPATOLOGY, 2013, 58 : 438A - 438A
  • [3] Pharmacokinetic Interaction Between the HCV Protease Inhibitor Boceprevir and Prednisone in Healthy Volunteers
    Jumes, Patricia
    Feng, Hwa Ping
    Chatterjee, Manash
    Xuan, Fengjuan
    Connolly, Sandra M.
    Wagner, John A.
    Butterton, Joan R.
    HEPATOLOGY, 2012, 56 : 1076A - 1076A
  • [4] PHARMACOKINETIC (PK) DRUG-DRUG INTERACTION BETWEEN SAMATASVIR (IDX719), A PAN-GENOTYPIC NS5A INHIBITOR, AND SIMEPREVIR IN HEALTHY VOLUNTEERS AND HCV-INFECTED SUBJECTS
    Zhou, X. J.
    Donovan, E.
    Chen, J.
    van Heeswijk, R.
    Sullivan-Bolyai, J. Z.
    Mayers, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S495 - S495
  • [5] NONCLINICAL PROFILE AND PHASE I RESULTS IN HEALTHY VOLUNTEERS FOR THE NOVEL AND POTENT HCV NS5A INHIBITOR GS-5885
    Link, John O.
    Bannister, Roy
    Beilke, Lisa D.
    Cheng, Guofeng
    Cornpropst, Melanie
    Corsa, Amoreena
    Dowdy, Eric
    Guo, Hongyan
    Kato, Darryl
    Kirschberg, Thorsten
    Liu, Hongtao
    Mitchell, Michael
    Matles, Mike
    Mogalian, Erik
    Mondou, Elsa
    Ohmstede, Carol
    Peng, Betty
    Scott, Robert W.
    Findlay, John W.
    Chittick, Greg E.
    Wang, Feng
    Alianti, John
    Sun, Jianyu
    Taylor, James
    Tian, Yang
    Xu, Lianhong
    Yang, Chris
    Yuen, Geoffrey J.
    Wang, Kelly
    Eisenberg, Eugene J.
    HEPATOLOGY, 2010, 52 (04) : 1215A - 1216A
  • [6] Pharmacokinetic Interaction Between the HCV Protease Inhibitor MK-5172 and Efavirenz in Normal Healthy Volunteers
    Talaty, Jennifer E.
    Caro, Luzelena
    Yeh, Wendy W.
    Fraser, Iain P.
    Guo, Zifang
    Butterfield, Kristin
    Reitmann, Christina
    Dunnington, Katherine M.
    DeGroot, Bruce J.
    Youngberg, Stephen P.
    Butterton, Joan R.
    HEPATOLOGY, 2013, 58 : 445A - 445A
  • [7] No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
    Feng, Hwa-Ping
    Guo, Zifang
    Caro, Luzelena
    Marshall, William L.
    Liu, Fang
    Panebianco, Deborah
    Vaddady, Pavan
    Barbour, April
    Reitmann, Christina
    Jumes, Patricia
    Gilmartin, Jocelyn
    Wolford, Dennis
    Valesky, Robert
    Martinho, Monika
    Butterton, Joan R.
    Iwamoto, Marian
    Fraser, Iain
    Webster, Lynn
    Yeh, Wendy W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (06): : 562 - 572
  • [8] An Improved Process for the Enantioselective Synthesis of HCV NS5A Inhibitor Elbasvir (MK-8742) Chiral Amine Intermediate
    Chapala, Vijaya Lakshmi
    Katari, Naresh Kumar
    Malavattu, Giri Prasad
    Kerru, Nagaraju
    Reddy, Pedavenkatagari Narayana
    Marisetti, Vishnu Murthy
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2021, 91 (05) : 932 - 938
  • [9] An Improved Process for the Enantioselective Synthesis of HCV NS5A Inhibitor Elbasvir (MK-8742) Chiral Amine Intermediate
    Vijaya Lakshmi Chapala
    Naresh Kumar Katari
    Giri Prasad Malavattu
    Nagaraju Kerru
    Pedavenkatagari Narayana Reddy
    Vishnu Murthy Marisetti
    Russian Journal of General Chemistry, 2021, 91 : 932 - 938
  • [10] Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
    Plaza, Zulema
    Soriano, Vincent
    Vispo, Eugenia
    del Mar Gonzalez, Maria
    Barreiro, Pablo
    Seclen, Eduardo
    Poveda, Eva
    ANTIVIRAL THERAPY, 2012, 17 (05) : 921 - 926
12345